ABOVE: © ISTOCK.COM, SELVANEGRA
Today, nearly six million people in the United States suffer from severe memory loss and other impairments caused by Alzheimer’s disease. By some estimates, another forty-six million or more are on their way to developing Alzheimer’s without even knowing it, and scores of long and costly clinical trials have failed. Unless scientists can figure out how to break the impasse against this dreaded disease, it could cost more than $2 trillion globally in the next decade. But despite these grim facts, many researchers argue that there are reasons for optimism, not least of which is a willingness to look outside the spotlight and try fundamentally different tactics.
One such researcher is Michela Gallagher who has been studying memory since the mid 1970s. When Gallagher first started out, Alzheimer’s disease was not even part of her thinking. Today, she is the driving force behind a phase three ...
